Gritstone Oncology (GRTS) PT Lowered to $9 at Barclays
Tweet
Share
E-mailGet Alerts GRTS Hot Sheet
Price: $0.03 --0%
Rating Summary:
7 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Rating Summary:
7 Buy, 4 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 9 | New: 13
Join SI Premium – FREE
Barclays analyst Geoff Meacham lowered the price target on Gritstone Oncology (NASDAQ: GRTS) to $9.00 (from $25.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Baidu (BIDU) PT Lowered to $150 at Benchmark on Near-Term Margin Concerns
- American Healthcare REIT, Inc (AHR) PT Raised to $68 at KeyBanc
- Bally's Corp (BALY) PT Lowered to $10; Truist Securities: 'Mixed results amidst a "going concern"'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
